World-renowned surgeon-scientist Dr. Adil Haider has been appointed as the Inaugural Chief Artificial Intelligence Officer at the Carle Illinois College of Medicine. CI MED is the world’s first engineering-based medical school. The appointment marks a major milestone in global medical education and health technology innovation.
Dr. Haider is the founder of Boston Health AI. He is widely respected for his work in clinical care, research leadership, and health equity. His career spans the United States, the United Arab Emirates, and Pakistan. This new role places him at the center of shaping how artificial intelligence transforms modern medicine.
As Chief AI Officer, Dr. Haider will lead the strategic vision for responsible AI adoption. His focus will be on education, research, and clinical innovation. The goal is to ensure AI solutions remain ethical, patient-centered, and clinically relevant.
Leadership Legacy at Aga Khan University and Beyond
Before joining CI MED, Dr. Haider served as Dean of the Aga Khan University Medical College for six and a half years. His tenure is considered transformative. Under his leadership, research funding increased fourfold. The institution achieved a top-100 global ranking.
The medical college also earned multiple international accreditations. These included ACGME-International and AACME recognition. Dr. Haider was known for his accessibility and mentorship. Students admired his open-door policy and hands-on leadership style.
He was also a popular figure on campus. His signature sneakers became a symbol of his connection with learners. His leadership helped position the institution as a global academic force.
Earlier in his career, Dr. Haider held senior roles at Johns Hopkins School of Medicine. He later served at Harvard Medical School and Brigham and Women’s Hospital. There, he led the Center for Surgery and Public Health.
Driving Responsible AI in Medical Education and Care
At CI MED, Dr. Haider will guide how AI is governed and evaluated. He will oversee its integration across medicine, engineering, and data science. The aim is to align innovation with real clinical needs.
He believes technology alone does not improve healthcare. Context, trust, and clinical reality matter most. His approach focuses on responsible deployment and thoughtful governance of AI systems.
CI MED Dean Mark Cohen praised the appointment. He said AI is now foundational to the future of medicine. Dr. Haider’s experience blends academic rigor, clinical excellence, and entrepreneurship.
Dr. Haider will also serve as Medical Director for Research Informatics at Carle Foundation Hospital. This role strengthens ties between research and real-world practice. He will additionally serve as Visiting Professor at the Siebel School of Computing and Data Science.
Global Impact Through Research and Health Technology
Dr. Haider has authored over 450 peer-reviewed publications. He has secured more than 200 million dollars in external research funding. He has mentored over 150 trainees worldwide.
In 2024, he founded Boston Health AI. The company operates in the US, UAE, and Pakistan. Its flagship product, Hami, is the world’s first AI clinical intelligence companion.
His mission is ambitious. He aims to improve care for one billion patients globally. The focus remains on ethical, scalable, and evidence-based AI solutions.
Dr. Haider’s journey reflects the power of leadership and innovation. His appointment strengthens CI MED’s role in shaping the future of healthcare.
